Evidence map›Paper›PMID 37876734›Full record

ArticleFrontiers in pharmacology2023

New pricing models for generic medicines to ensure long-term sustainable competition in Europe.

Clement Francois, Gabriela Gawlik, Jorge Mestre-Ferrandiz, Adrian Pana, Julian Perelman, John Yfantopoulos, Steven Simoens

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 6 countries.

Clement FrancoisAix Marseille University, Marseille, France.
Gabriela GawlikPutnam PHMR, Krakow, Poland.
Jorge Mestre-FerrandizUniversidad Carlos III, Madrid, Spain.
Adrian PanaDepartment of Public Health, Babes Bolyai University, Cluj Napoca, Romania.
Julian PerelmanNOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon, Lisbon, Portugal.
John YfantopoulosIPOKE Research Institute, MBA-University of Athens, Athens, Greece.
Steven SimoensKU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
Aix-Marseille Université · FRBabeș-Bolyai University · ROKU Leuven · BENational and Kapodistrian University of Athens · GRUniversidad Carlos III de Madrid · ESUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

competitionEuropegeneric medicinespricingsustainability

Identifiers

PMID37876734
PMCPMC10593415
OpenAlexW4387453676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.